Skip to main content
. 2017 Apr 19;9(1):15–32. doi: 10.1007/s13238-017-0408-4

Figure 6.

Figure 6

Tumor distribution of anti-Her2 mAbs with different affinities. Adapted from Rudnick et al. (2011)